404 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Omnia Family Wealth LLC

Omnia Family Wealth LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the first quarter, Holdings Channel.com reports. The institutional investor acquired 404 shares of the medical equipment provider’s stock, valued at approximately $200,000.

Other institutional investors have also recently bought and sold shares of the company. Castleark Management LLC grew its stake in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the period. Ewing Morris & Co. Investment Partners Ltd. bought a new position in Intuitive Surgical in the 4th quarter valued at $454,000. Whalerock Point Partners LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $209,000. Tounjian Advisory Partners LLC bought a new position in Intuitive Surgical in the 1st quarter valued at $5,152,000. Finally, Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and reduced their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Evercore ISI cut their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird cut their price target on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Finally, Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $521.63 on Thursday. The stock’s 50-day simple moving average is $530.03 and its 200 day simple moving average is $536.86. The stock has a market capitalization of $186.96 billion, a price-to-earnings ratio of 76.49, a price-to-earnings-growth ratio of 5.55 and a beta of 1.67. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the firm posted $1.50 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,998 shares of company stock valued at $2,611,577. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.